It sounds like a conspiracy theory, but research into deadly diseases often doesn’t get funding because pharmaceutical companies can’t make money out of it. This includes cures for malaria, Ebola, and the Zika virus. That’s the blunt statement from the University of Sydney’s associate professor Matthew Todd, who believes open-source research is key to solving this issue as it cuts cash out of the equation.